ACADIA Pharmaceuticals Inc. (ACAD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ACADIA Pharmaceuticals In...

    NASDAQ: ACAD · Real-Time Price · USD
    21.05
    -0.16 (-0.75%)
    At close: Sep 26, 2025, 3:59 PM
    21.28
    1.09%
    After-hours: Sep 26, 2025, 06:02 PM EDT

    ACADIA Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 957.8M 726.44M 517.24M 484.14M
    Cost of Revenue
    		 81.84M 45.73M 10.17M 19.14M
    Gross Profit
    		 875.96M 680.71M 507.07M 465M
    Operating Income
    		 230.79M -73.38M -223.6M -170.44M
    Interest Income
    		 25.46M 17.23M 6.61M 591K
    Pretax Income
    		 258.07M -51.04M -213.44M -167.52M
    Net Income
    		 226.45M -61.29M -215.97M -167.87M
    Selling & General & Admin
    		 488.43M 402.47M 369.09M 396.03M
    Research & Development
    		 303.25M 351.62M 361.57M 239.41M
    Other Expenses
    		 -146.51M n/a 3.54M 2.33M
    Operating Expenses
    		 645.16M 754.09M 730.66M 635.44M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a 9.4M 5.5M 41.8M
    Cost & Expenses
    		 727M 799.82M 740.83M 654.58M
    Income Tax Expense
    		 31.62M 10.25M 2.53M 351K
    Shares Outstanding (Basic)
    		 165.72M 163.82M 161.68M 160.49M
    Shares Outstanding (Diluted)
    		 166.36M 163.82M 161.68M 160.49M
    EPS (Basic)
    		 1.37 -0.37 -1.34 -1.05
    EPS (Diluted)
    		 1.36 -0.37 -1.34 -1.05
    EBITDA
    		 100.16M -67.83M -221.57M -167.09M
    EBIT
    		 84.28M -73.38M -223.6M -170.44M
    Depreciation & Amortization
    		 15.88M 5.55M 2.03M 3.34M

    Add to Watchlist